冠状动脉微血管功能障碍在心血管疾病谱中的作用:JACC最新综述
该综述阐述冠状动脉微血管功能障碍(CMD)的病理生理机制及其在不同心血管疾病中的机制与预后作用,涉及无阻塞性冠脉疾病的心绞痛、阻塞性冠脉疾病、非缺血性心肌病、Takotsubo综合征及心衰(尤其射血分数保留型)。尽管CMD在这些疾病中具有病理生理和预后意义,但目前尚无特异性治疗,需进一步研究以实现个体化治疗。
要点
- CMD是多种心血管疾病(包括非阻塞性冠脉疾病心绞痛、心衰等)的共同机制。
- CMD在这些疾病中具有预后意义,但目前缺乏特异性治疗。
- 综述讨论了CMD的诊断方式及近期临床研究提示的潜在治疗策略。
核心结论
- CMD涉及多种病理机制,在多种心血管疾病中起重要作用,但尚无特异性治疗,需进一步研究以实现个体化治疗。
研究设计与样本
- 本文为JACC状态综述,描述CMD的病理生理机制及其在不同心血管疾病中的机制和预后作用,并讨论诊断方式和潜在治疗策略。
主要发现
- CMD在无阻塞性冠脉疾病的心绞痛、阻塞性冠脉疾病、非缺血性心肌病、Takotsubo综合征及心衰(尤其射血分数保留型)中起重要作用。
- CMD在这些疾病中具有病理生理和预后作用,但目前无特异性治疗。
临床怎么用
- 临床应认识到CMD是多种心血管疾病的共同机制,但目前尚无特异性治疗,需关注相关研究进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronary microvascular dysfunction (CMD) encompasses several pathogenetic mechanisms involving coronary microcirculation and plays a major role in determining myocardial ischemia in patients with angina without obstructive coronary artery disease, as well as in several other conditions, including obstructive coronary artery disease, nonischemic cardiomyopathies, takotsubo syndrome, and heart failure, especially the phenotype associated with preserved ejection fraction. Unfortunately, despite the identified pathophysiological and prognostic role of CMD in several conditions, to date, there is no specific treatment for CMD. Due to the emerging role of CMD as common denominator in different clinical phenotypes, additional research in this area is warranted to provide personalized treatments in this "garden variety" of patients. The purpose of this review is to describe the pathophysiological mechanisms of CMD and its mechanistic and prognostic role across different cardiovascular diseases. We will also discuss diagnostic modalities and the potential therapeutic strategies resulting from recent clinical studies.
引用
- Del Buono MG, Montone RA, Camilli M, et al. Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 34556322. doi:10.1016/j.jacc.2021.07.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。